Insider · CIK 0001792810
Richard C Pasternak
Files at MIST (Milestone Pharmaceuticals Inc.). First filing Oct 21, 2022, latest Oct 21, 2022.
In brief
Richard C Pasternak files SEC Form 4 as director at MIST (Milestone Pharmaceuticals Inc.). Since Oct 21, 2022, Richard C Pasternak has reported 1 open-market buy worth $52k and 0 open-market sells worth $0, the latest filed on Oct 21, 2022.
A track record needs three past buys with six months of prices behind them; Richard C Pasternak has 0, so none is measured yet.
The newest scored trade: bought $52k of MIST on Oct 20, 2022, filed Oct 21, 2022, scored 53 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MIST: Milestone Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Milestone Pharmaceuticals Inc. | $52k 10,000 shares | - | +28% from low-45% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 20, 2022 | MIST Milestone Pharmaceuticals Inc. | POpen-market purchase Common Shares | +10,000 | $5.20 | $52k | 10,000 | Oct 21, 2022 |
Questions about Richard C Pasternak
Answered from the filings on this page, as of the latest one.
Is Richard C Pasternak buying or selling?
Not in the last 12 months. Richard C Pasternak's latest open-market trade on SEC Form 4 was bought $52k of MIST on Oct 20, 2022.
How did Richard C Pasternak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard C Pasternak has 0.
Where does Richard C Pasternak file Form 4?
Richard C Pasternak has filed Form 4 at MIST (Milestone Pharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.